MedPath
NMPA Approval

Montelukast Sodium Oral Granules

国药准字H20243458

April 7, 2024

Drug Information

孟鲁司特钠颗粒

颗粒剂

4mg(以孟鲁司特计)

化学药品

April 7, 2024

Company Information

Applicant Company

四川省彭州工业开发区柏江北路368号

Manufacturing Company

四川省彭州工业开发区柏江北路368号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

孟鲁司特钠颗粒 - NMPA 批准文号 | MedPath